참고문헌 (57)

1. [1] Graham TA , Sottoriva A. Measuring cancer evolution from the genome . J Pathol . 2017 ; 241 ( 2 ): 183 ？ 191 . 27741350 

   상세보기

2. [2] Ferlay J , Colombet M , Soerjomataram I , et al . Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018 . Eur J Cancer . 2018 ; 103 : 356 ？ 387 . 30100160 

   상세보기

3. [3] Jemal A , MM C , DeSantis C , et al . Global patterns of cancer incidence and mortality rates and trends . Cancer Epidemiol Biomarkers Prev . 2010 ; 19 ( 8 ): 1893 ？ 1907 . 20647400 

4. [4] Carracedo A , Cantley LC , Pandolfi PP . Cancer metabolism: fatty acid oxidation in the limelight . Nat Rev Cancer . 2013 ; 13 ( 4 ): 227 ？ 232 . 23446547 

   상세보기

5. [5] Bhattacharya B , Mohd Omar MF , Soong R . The Warburg effect and drug resistance . Br J Pharmacol . 2016 ; 173 ( 6 ): 970 ？ 979 . 26750865 

   상세보기

6. [6] Potter M , Newport E , Morten KJ . The Warburg effect: 80 years on . Biochem Soc Trans . 2016 ; 44 ( 5 ): 1499 ？ 1505 . 27911732 

   상세보기

7. [7] Fu Y , Liu S , Yin S , et al . The reverse Warburg effect is likely to be an Achilles’ heel of cancer that can be exploited for cancer therapy . Oncotarget . 2017 [ Published 2017 May 25 ]; 8 ( 34 ): 57813 ？ 57825 . 28915713 

   상세보기

8. [8] Vaupel P , Multhoff G . Revisiting the Warburg effect: historical dogma versus current understanding . J Physiol . 2021 ; 599 ( 6 ): 1745 ？ 1757 . 33347611 

   상세보기

9. [9] Lin L , Yee SW , Kim RB , et al . SLC transporters as therapeutic targets: emerging opportunities . Nat Rev Drug Discov . 2015 ; 14 ( 8 ): 543 ？ 560 . 26111766 

10. [10] Liu X . SLC Family Transporters . Adv Exp Med Biol . 2019 ; 1141 : 101 ？ 202 . 31571165 

11. [11] Halestrap AP . The SLC16 gene family - structure, role and regulation in health and disease . Mol Aspects Med . 2013 ; 34 ( 2？3 ): 337 ？ 349 . 23506875 

12. [12] Felmlee MA , Jones RS , Rodriguez-Cruz V , et al . (SLC16): function, Regulation, and Role in Health and Disease . Pharmacol Rev . 2020 ; 72 ( 2 ): 466 ？ 485 . 32144120 

13. [13] Halestrap AP , The MD . SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond . Pflugers Arch . 2004 ; 447 ( 5 ): 619 ？ 628 . 12739169 

14. [14] Halestrap AP . Monocarboxylic acid transport . Compr Physiol . 2013 ; 3 ( 4 ): 1611 ？ 1643 . 24265240 

15. [15] AP H , Wilson MC . The monocarboxylate transporter family？role and regulation . IUBMB Life . 2012 ; 64 ( 2 ): 109 ？ 119 . 22162139 

    상세보기

16. [16] Gallagher-Colombo S , Maminishkis A , Tate S , et al . Modulation of MCT3 expression during wound healing of the retinal pigment epithelium . Invest Ophthalmol Vis Sci . 2010 ; 51 ( 10 ): 5343 ？ 5350 . 20505202 

    상세보기

17. [17] Sun S , Li H , Chen J , et al . No Longer an Inert and End-Product of Glycolysis . Physiology (Bethesda) . 2017 ; 32 ( 6 ): 453 ？ 463 . 29021365 

18. [18] Wang N , Jiang X , Zhang S , et al . Structural basis of human monocarboxylate transporter 1 inhibition by anti-cancer drug candidates . Cell . 2021 ; 184 ( 2 ): 370 ？ 383.e13 . 33333023 

    상세보기

19. [19] Marquard J , Welters A , Buschmann T , et al . Association of exercise-induced hyperinsulinaemic hypoglycaemia with MCT1-expressing insulinoma . Diabetologia . 2013 ; 56 ( 1 ): 31 ？ 35 . 23073708 

    상세보기

20. [20] Nikooie R , Rajabi H , Gharakhanlu R , et al . Exercise-induced changes of MCT1 in cardiac and skeletal muscles of diabetic rats induced by high-fat diet and STZ . J Physiol Biochem . 2013 ; 69 ( 4 ): 865 ？ 877 . 23712504 

21. [21] Gill RK , Saksena S , Alrefai WA , et al . Expression and membrane localization of MCT isoforms along the length of the human intestine . Am J Physiol Cell Physiol . 2005 ; 289 ( 4 ): C846 ？ C852 . 15901598 

    상세보기

22. [22] Lin WR , Chiang JM , Lim SN , et al . Dynamic bioenergetic alterations in colorectal adenomatous polyps and adenocarcinomas . EBioMedicine . 2019 ; 44 : 334 ？ 345 . 31122841 

23. [23] Murakami Y , Kohyama N , Kobayashi Y , et al . Functional characterization of human monocarboxylate transporter 6 (SLC16A5) . Drug Metab Dispos . 2005 ; 33 ( 12 ): 1845 ？ 1851 . 16174808 

    상세보기

24. [24] Hugo SE , Cruz-Garcia L , Karanth S , et al . A monocarboxylate transporter required for hepatocyte secretion of ketone bodies during fasting . Genes Dev . 2012 ; 26 ( 3 ): 282 ？ 293 . 22302940 

    상세보기

25. [25] Karanth S , Schlegel A . The Monocarboxylate Transporter SLC16A6 Regulates Adult Length in Zebrafish and Is Associated With Height in Humans . Front Physiol . 2019 ; 9 : 1936 . 30692937 

26. [26] Grijota-Martinez C , Barez-Lopez S , Gomez-Andres D , et al . MCT8 Deficiency: the Road to Therapies for a Rare Disease . Front Neurosci . 2020 ; 14 : 380 . 32410949 

    상세보기

27. [27] van Mullem AA , ALM VG , Visser WE , et al . Effects of thyroid hormone transporters MCT8 and MCT10 on nuclear activity of T3 . Mol Cell Endocrinol . 2016 ; 437 : 252 ？ 260 . 27492966 

    상세보기

28. [28] Uemura S , Mochizuki T , Kurosaka G , et al . Functional analysis of human aromatic amino acid transporter MCT10/TAT1 using the yeast Saccharomyces cerevisiae . Biochim Biophys Acta Biomembr . 2017 ; 1859 ( 10 ): 2076 ？ 2085 . 28754537 

    상세보기

29. [29] Perez-Escuredo J , Van Hee VF , Sboarina M , et al . Monocarboxylate transporters in the brain and in cancer . Biochim Biophys Acta . 2016 ; 1863 ( 10 ): 2481 ？ 2497 . 26993058 

30. [30] Rusu V , Hoch E , Mercader JM , et al . Type 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct Mechanisms . Cell . 2017 ; 170 ( 1 ): 199 ？ 212.e20 . 28666119 

    상세보기

31. [31] Castorino JJ , Gallagher-Colombo SM , Levin AV , et al . Juvenile cataract-associated mutation of solute carrier SLC16A12 impairs trafficking of the protein to the plasma membrane . Invest Ophthalmol Vis Sci . 2011 ; 52 ( 9 ): 6774 ？ 6784 . 21778275 

32. [32] McClintick JN , Tischfield JA , Deng L , et al . Ethanol activates immune response in lymphoblastoid cells . Alcohol . 2019 ; 79 : 81 ？ 91 . 30639126 

    상세보기

33. [33] Knopfel T , Atanassoff A , Hernando N , et al . Renal localization and regulation by dietary phosphate of the MCT14 orphan transporter . PLoS One . 2017 ; 12 ( 6 ): e0177942 . 28662032 

    상세보기

34. [34] Wu T , Dai Y . Tumor microenvironment and therapeutic response . Cancer Lett . 2017 ; 387 : 61 ？ 68 . 26845449 

    상세보기

35. [35] Martincorena I , Campbell PJ Somatic mutation in cancer and normal cells [published correction appears in Science . 2016 Mar 4 ; 351 ( 6277 ). 

36. [36] Zugazagoitia J , Guedes C , Ponce S , et al . Challenges in Cancer Treatment . Clin Ther . 2016 ; 38 ( 7 ): 1551 ？ 1566 . 27158009 

37. [37] Lee YT , Tan YJ , Oon CE . Molecular targeted therapy: treating cancer with specificity . Eur J Pharmacol . 2018 ; 834 : 188 ？ 196 . 30031797 

    상세보기

38. [38] Hinshaw DC , Shevde LA . The Tumor Microenvironment Innately Modulates Cancer Progression . Cancer Res . 2019 ; 79 ( 18 ): 4557 ？ 4566 . 31350295 

    상세보기

39. [39] Soysal SD , Tzankov A , Muenst SE . Role of the Tumor Microenvironment in Breast Cancer . Pathobiology . 2015 ; 82 ( 3？4 ): 142 ？ 152 . 26330355 

40. [40] Jarosz-Biej M , Smolarczyk R , Cicho T , et al . Tumor Microenvironment as A “Game Changer” in Cancer Radiotherapy . Int J Mol Sci . 2019 ; 20 ( 13 ): 3212 . 

41. [41] Icard P , Shulman S , Farhat D , et al . How the Warburg effect supports aggressiveness and drug resistance of cancer cells? Drug Resist Updat . 2018 ; 38 : 1 ？ 11 . 29857814 

42. [42] Watson MJ , Vignali PDA , Mullett SJ , et al . Metabolic support of tumour-infiltrating regulatory T cells by lactic acid . Nature . 2021 ; 591 ( 7851 ): 645 ？ 651 . 33589820 

43. [43] Xie J , Zhu Z , Cao Y , et al . Solute carrier transporter superfamily member SLC16A1 is a potential prognostic biomarker and associated with immune infiltration in skin cutaneous melanoma . Channels (Austin) . 2021 ; 15 ( 1 ): 483 ？ 495 . 34254872 

44. [44] Sohrabi E , Moslemi M , Rezaie E , et al . The tissue expression of MCT3, MCT8, and MCT9 genes in women with breast cancer [published online ahead of print, 2021 Jun 7] . Genes Genomics . 2021 ; 10.1007/s13258-021-01116-w . 

    상세보기

45. [45] Choi SH , Kim MY , Yoon YS , et al . Hypoxia-induced RelA/p65 derepresses SLC16A3 (MCT4) by downregulating ZBTB7A . Biochim Biophys Acta Gene Regul Mech . 2019 ; 1862 ( 8 ): 771 ？ 785 . 31271899 

46. [46] Drogemoller BI , Monzon JG , Bhavsar AP , et al . Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer . JAMA Oncol . 2017 ; 3 ( 11 ): 1558 ？ 1562 . 28448657 

47. [47] Dai W , Liu H , Chen K , et al . Genetic variants in PDSS1 and SLC16A6 of the ketone body metabolic pathway predict cutaneous melanoma-specific survival . Mol Carcinog . 2020 ; 59 ( 6 ): 640 ？ 650 . 32232919 

    상세보기

48. [48] Pertega-Gomes N , Vizcaino JR , Felisbino S , et al . Epigenetic and oncogenic regulation of SLC16A7 (MCT2) results in protein over-expression, impacting on signalling and cellular phenotypes in prostate cancer . Oncotarget . 2015 ; 6 ( 25 ): 21675 ？ 21684 . 26035357 

    상세보기

49. [49] Lamb R , Harrison H , Hulit J , et al . Mitochondria as new therapeutic targets for eradicating cancer stem cells: quantitative proteomics and functional validation via MCT1/2 inhibition . Oncotarget . 2014 ; 5 ( 22 ): 11029 ？ 11037 . 25415228 

    상세보기

50. [50] Mei J , Hu K , Peng X , et al . Decreased expression of SLC16A12 mRNA predicts poor prognosis of patients with clear cell renal cell carcinoma . Medicine (Baltimore) . 2019 ; 98 ( 30 ): e16624 . 31348313 

51. [51] Wu L , Qu X . Cancer biomarker detection: recent achievements and challenges . Chem Soc Rev . 2015 ; 44 ( 10 ): 2963 ？ 2997 . 25739971 

    상세보기

52. [52] Andor N , Maley CC , Ji HP . Genomic Instability in Cancer: teetering on the Limit of Tolerance . Cancer Res . 2017 ; 77 ( 9 ): 2179 ？ 2185 . 28432052 

    상세보기

53. [53] Tubbs A , Nussenzweig A . Endogenous DNA Damage as a Source of Genomic Instability in Cancer . Cell . 2017 ; 168 ( 4 ): 644 ？ 656 . 28187286 

    상세보기

54. [54] Vinay DS , Ryan EP , Pawelec G , et al . Immune evasion in cancer: mechanistic basis and therapeutic strategies . Semin Cancer Biol . 2015 ; 35 ( Suppl ): S185 ？ S198 . 25818339 

55. [55] Ramos-Casals M , Brahmer JR , Callahan MK , et al . Immune-related adverse events of checkpoint inhibitors . Nat Rev Dis Primers . 2020 ; 6 ( 1 ): 38 . 32382051 

56. [56] Fujii SI , Shimizu K . Immune Networks and Therapeutic Targeting of iNKT Cells in Cancer . Trends Immunol . 2019 ; 40 ( 11 ): 984 ？ 997 . 31676264 

    상세보기

57. [57] Najafi M , Mortezaee K , Majidpoor J . Cancer stem cell (CSC) resistance drivers . Life Sci . 2019 ; 234 : 116781 . 31430455